subscribeSubscribe
HHS asks Supreme Court to reject Pfizer`s anti-kickback appeal

HHS asks Supreme Court to reject Pfizer`s anti-kickback appeal
Kevin Dunleavy FIERCEPHARMA
15 Dec 2022
Share Share
Pfizer gains powerful allies in its Vyndaqel copay case

Pfizer gains powerful allies in its Vyndaqel copay case
Fraiser Kansteiner FIERCEPHARMA
15 Nov 2022
Share Share
Pfizer petitions Supreme Court over anti-kickback case

Pfizer petitions Supreme Court over anti-kickback case
Zachary Brennan ENDPTS
18 Oct 2022
Share Share
Pfizer’s VYNDAQEL/VYNDAMAX Reduced the Risk of All-Cause Mortality

Pfizer’s VYNDAQEL/VYNDAMAX Reduced the Risk of All-Cause Mortality
BIOSPACE
20 Dec 2021
Share Share
Pfizer’s VYNDAQEL/VYNDAMAX Reduces Risk of All-Cause Mortality by 41% in ATTR-CM

Pfizer’s VYNDAQEL/VYNDAMAX Reduces Risk of All-Cause Mortality by 41% in ATTR-CM
BUSINESSWIRE
20 Dec 2021
Share Share
Pfizer fails in another challenge to U.S. anti-kickback policies

Pfizer fails in another challenge to U.S. anti-kickback policies
Kevin Dunleavy FIERCEPHARMA
02 Oct 2021
Share Share
Dutch HTA Calls for Big Discount For Pfizer’s Vyndaqel

Dutch HTA Calls for Big Discount For Pfizer’s Vyndaqel
Francesca Bruce PINK SHEET
31 Aug 2021
Share Share
Pfizer`s new Vyndaqel, Vyndamax reach blockbuster threshold

Pfizer`s new Vyndaqel, Vyndamax reach blockbuster threshold
E. Sagonowsky FIERCE PHARMA
03 Feb 2021
Share Share
Pfizer`s Vyndaqel zooms toward blockbusterland, even amid COVID

Pfizer`s Vyndaqel zooms toward blockbusterland, even amid COVID
Angus Liu FIERCE PHARMA
06 Nov 2020
Share Share
Pfizer targets anti-kickback rules in Vyndaqel Medicare suit

Pfizer targets anti-kickback rules in Vyndaqel Medicare suit
Angus Liu FIERCE PHARMA
30 Jun 2020
Share Share